(Q35057104)

6 August 2017

title

Failure after radical prostatectomy (English)

1 reference

6 August 2017

Endre Z Neulander

1

1 reference

6 August 2017

Mark S Soloway

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

61

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

30-36

1 reference

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Adjuvant radiotherapy in patients post radical prostatectomy with tumor extending through capsule or positive seminal vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Is there a role for digital rectal examination in the followup of patients after radical prostatectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Intermittent androgen suppression in the treatment of metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Treatment with finasteride following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901918-0

7 January 2021

10.1016/S0090-4295(02)01918-0

Identifiers

DOI

1 reference

6 August 2017

1 reference